Tromsø, Norway, December 19, 2023 –ArcticZymes Technologies ASA (OSE: AZT) enters an agreement with Biomatter(Biomatter Designs UAB) to develop new enzyme-based products.
ArcticZymes Technologies (AZT) has entered a partnership agreement with Biomatter, a leading enzyme design company. Leveraging Biomatter’s AI-driven Intelligent ArchitectureTM platform, the companies will co-develop new and improved products for AZT’s enzyme portfolio.
The Intelligent ArchitectureTM platform combines generative AI and physical modelling to address the current limitations of enzyme engineering accuracy andtime. The unique capabilities offered by the platform enables the design of enzymes with previously unattainable functions and properties. By leveraging this technology and Biomatter’s expertise, AZT will be able to expand its offering towards new and existing customers in both the molecular tools and biomanufacturing businesses.
Michael Akoh, CEOof ArcticZymes said:
“Working with Biomatter is a very exciting step in exploring alternatives to classic proteindesign methods. This partnership enhances ArcticZymes biotechnology toolbox and increases our innovation capabilities. It will play a pivotal role in accelerating additions to our product portfolio. At the same time, it is in line with our strategy to seek partnership opportunities across the value chain to create long term growth”
Laurynas Karpus,co-founder and CEO of Biomatter said:
“ArcticZymes has been a long-standing enzyme supply leader, renowned for its unique enzyme portfolio. We’re excited to collaborate with AZT, harnessing our Intelligent Architecture™ platform to explore new frontiers in life sciences enzymes, and to further expand AZT’s capabilities and offerings.”
